FibroGen, Inc. Forecast, price target & analysts
FibroGen, Inc. Target price 2025 - Analyst rating & recommendation
FibroGen, Inc. Classifications & Recommendation:
FibroGen, Inc. Price Target
| Target Price | $43.86 |
| Price | $11.00 |
| Potential |
298.73%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target FibroGen, Inc. 2026 .
The average FibroGen, Inc. target price is $43.86.
This is
298.73%
register free of charge
$45.15
310.45%
register free of charge
$43.43
294.82%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend FibroGen, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the FibroGen, Inc. stock has an average upside potential 2026 of
298.73%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 29.62 | 6.83 |
| 36.71% | 76.93% | |
| EBITDA Margin | -433.05% | -811.94% |
| 32.49% | 87.49% | |
| Net Margin | -160.63% | -337.07% |
| 73.55% | 109.84% |
4 Analysts have issued a sales forecast FibroGen, Inc. 2025 . The average FibroGen, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an FibroGen, Inc. EBITDA forecast 2025. The average FibroGen, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 FibroGen, Inc. Analysts have issued a net profit forecast 2025. The average FibroGen, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -11.88 | -5.70 |
| 83.73% | 52.02% | |
| P/E | negative | |
| EV/Sales | 16.72 |
4 Analysts have issued a FibroGen, Inc. forecast for earnings per share. The average FibroGen, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current FibroGen, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 13 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 20 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
